Literature DB >> 29570238

Relationship between individual and family characteristics and psychosocial factors in persons with familial pancreatic cancer.

Meghan Underhill1, Fangxin Hong2, Janette Lawrence3, Traci Blonquist2, Sapna Syngal4,5.   

Abstract

OBJECTIVE: Describe relationships between self-reported personal demographics or familial characteristics and psychosocial outcomes (Patient Reported Outcome Measurement Information System Global Health, Impact of Event Scale-Revised [pancreatic cancer risk-related distress], cancer risk perception, and cancer worry) in participants with inherited or familial pancreatic cancer risk.
METHODS: A multisite cross sectional survey of adults with elevated pancreatic cancer risk based on family history. All variables were summarized with descriptive statistics. To assess univariate associations, t test and chi-square/Fisher's exact test were used, and backward model selection was used in multivariable analysis.
RESULTS: Respondents (N = 132) reported moderate to high frequency of cancer worry and 59.3% perceived a 50% or more perceived lifetime risk for pancreatic cancer, which far exceeds objective risk estimates. Cancer worry was associated with female gender (P = .03) and pancreatic cancer risk specific distress (P = .05). Higher-risk perception was associated with having a high school education or less (P = .001), higher distress (P = .02), and cancer worry (P = .008) and family cancer death experience (P = .02). Higher distress was associated with experience as a caregiver to a seriously ill family member in the past 5 years (P = .006).
CONCLUSIONS: Individuals with inherited or familial pancreatic cancer risk experience cancer worry, distress, and have increased risk perception, particularly in the period following caring for a loved one with cancer. Routine evaluation of distress in this setting, as well as the development of supportive care resources, will help support patients living with risk for pancreatic cancer.
Copyright © 2018 John Wiley & Sons, Ltd.

Entities:  

Keywords:  cancer; oncology; pancreatic cancer risk; patient reported outcomes; psychosocial

Mesh:

Year:  2018        PMID: 29570238      PMCID: PMC7008775          DOI: 10.1002/pon.4712

Source DB:  PubMed          Journal:  Psychooncology        ISSN: 1057-9249            Impact factor:   3.894


  27 in total

1.  Repeated participation in pancreatic cancer surveillance by high-risk individuals imposes low psychological burden.

Authors:  Ingrid C A W Konings; Grace N Sidharta; Femme Harinck; Cora M Aalfs; Jan-Werner Poley; Jacobien M Kieffer; Marianne A Kuenen; Ellen M A Smets; Anja Wagner; Jeanin E van Hooft; Anja van Rens; Paul Fockens; Marco J Bruno; Eveline M A Bleiker
Journal:  Psychooncology       Date:  2015-12-03       Impact factor: 3.894

2.  The Theory of Genetic Vulnerability: a Roy model exemplar.

Authors:  Rebekah J Hamilton; Barbara J Bowers
Journal:  Nurs Sci Q       Date:  2007-07       Impact factor: 0.883

3.  Pancreatic cancer risk counselling and screening: impact on perceived risk and psychological functioning.

Authors:  Christine Maheu; Andrea Vodermaier; Heidi Rothenmund; Steve Gallinger; Paola Ardiles; Kara Semotiuk; Spring Holter; Saumea Thayalan; Mary Jane Esplen
Journal:  Fam Cancer       Date:  2010-12       Impact factor: 2.375

4.  Minimally important differences were estimated for six Patient-Reported Outcomes Measurement Information System-Cancer scales in advanced-stage cancer patients.

Authors:  Kathleen J Yost; David T Eton; Sofia F Garcia; David Cella
Journal:  J Clin Epidemiol       Date:  2011-05       Impact factor: 6.437

5.  Measuring perceptions of breast cancer risk.

Authors:  Andrea Gurmankin Levy; Judy Shea; Sankey V Williams; Alex Quistberg; Katrina Armstrong
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2006-10       Impact factor: 4.254

6.  Living my family's story: identifying the lived experience in healthy women at risk for hereditary breast cancer.

Authors:  Meghan L Underhill; Robin M Lally; Marc T Kiviniemi; Christine Murekeyisoni; Suzanne S Dickerson
Journal:  Cancer Nurs       Date:  2012 Nov-Dec       Impact factor: 2.592

7.  PROMIS measures of pain, fatigue, negative affect, physical function, and social function demonstrated clinical validity across a range of chronic conditions.

Authors:  Karon F Cook; Sally E Jensen; Benjamin D Schalet; Jennifer L Beaumont; Dagmar Amtmann; Susan Czajkowski; Darren A Dewalt; James F Fries; Paul A Pilkonis; Bryce B Reeve; Arthur A Stone; Kevin P Weinfurt; David Cella
Journal:  J Clin Epidemiol       Date:  2016-03-04       Impact factor: 6.437

8.  Psychological side effects of breast cancer screening.

Authors:  C Lerman; B Trock; B K Rimer; C Jepson; D Brody; A Boyce
Journal:  Health Psychol       Date:  1991       Impact factor: 4.267

9.  BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: a PACGENE study.

Authors:  David B Zhen; Kari G Rabe; Steven Gallinger; Sapna Syngal; Ann G Schwartz; Michael G Goggins; Ralph H Hruban; Michele L Cote; Robert R McWilliams; Nicholas J Roberts; Lisa A Cannon-Albright; Donghui Li; Kelsey Moyes; Richard J Wenstrup; Anne-Renee Hartman; Daniela Seminara; Alison P Klein; Gloria M Petersen
Journal:  Genet Med       Date:  2014-11-20       Impact factor: 8.822

10.  Factors associated with cancer worries in individuals participating in annual pancreatic cancer surveillance.

Authors:  Ingrid C A W Konings; Femme Harinck; Marianne A Kuenen; Grace N Sidharta; Jacobien M Kieffer; Cora M Aalfs; Jan-Werner Poley; Ellen M A Smets; Anja Wagner; Anja van Rens; Frank P Vleggaar; Margreet G E M Ausems; Paul Fockens; Jeanin E van Hooft; Marco J Bruno; Eveline M A Bleiker
Journal:  Fam Cancer       Date:  2017-01       Impact factor: 2.375

View more
  3 in total

1.  Pancreatic cancer risk to siblings of probands in bilineal cancer settings.

Authors:  Kari G Rabe; Maria A Stevens; Amanda Toledo Hernández; Shruti Chandra; Joleen M Hubbard; Jennifer L Kemppainen; Shounak Majumder; Gloria M Petersen
Journal:  Genet Med       Date:  2022-02-25       Impact factor: 8.864

2.  Novel Models of Genetic Education and Testing for Pancreatic Cancer Interception: Preliminary Results from the GENERATE Study.

Authors:  C Sloane Furniss; Matthew B Yurgelun; Chinedu Ukaegbu; Pamela E Constantinou; Catherine C Lafferty; Eliana R Talcove-Berko; Alison N Schwartz; Jill E Stopfer; Meghan Underhill-Blazey; Barbara Kenner; Scott H Nelson; Sydney Okumura; Sherman Law; Alicia Y Zhou; Tara B Coffin; Nicolette J Rodriguez; Hajime Uno; Allyson J Ocean; Florencia McAllister; Andrew M Lowy; Scott M Lippman; Alison P Klein; Lisa Madlensky; Gloria M Petersen; Judy E Garber; Michael G Goggins; Anirban Maitra; Sapna Syngal
Journal:  Cancer Prev Res (Phila)       Date:  2021-10-08

3.  Health behaviours and beliefs in individuals with familial pancreatic cancer.

Authors:  Meghan Underhill-Blazey; Traci Blonquist; Janette Lawrence; Fangxin Hong; Matthew B Yurgelun; Sapna Syngal
Journal:  Fam Cancer       Date:  2019-10       Impact factor: 2.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.